HER2-NEGATIVE BREAST CARCINOMA
Clinical trials for HER2-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HER2-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HER2-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine aims to train immune system against breast cancer stem cells
⭐️ VACCINE ⭐️ OngoingThis early-phase trial tests a DNA vaccine called STEMVAC in 42 people with advanced HER2-negative breast cancer. The vaccine is designed to help the immune system recognize and attack cancer stem cells, which are often resistant to standard treatments. The main goals are to chec…
Matched conditions: HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:57 UTC
-
Could a lower dose of tamoxifen be just as good for early breast cancer?
Disease control TerminatedThis study compares low-dose tamoxifen to standard hormone therapy (aromatase inhibitors) in postmenopausal women with low-risk, hormone-positive early-stage breast cancer. The goal is to see if low-dose tamoxifen works as well at preventing cancer return while possibly having fe…
Matched conditions: HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 04:06 UTC
-
New combo therapy aims to outsmart resistant breast cancer
Disease control OngoingThis early-phase study tests a drug called berzosertib combined with radiation therapy for people with certain types of breast cancer that no longer respond to chemotherapy. The goal is to find the safest dose and see if the combination can shrink or stabilize tumors better than …
Matched conditions: HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Daily radiation may give better breast appearance after cancer treatment
Symptom relief OngoingThis study tests a once-daily radiation schedule for women with low-risk, hormone-sensitive breast cancer. The goal is to see if this shorter treatment (5 days in a row) leads to better breast appearance compared to the standard every-other-day schedule. About 48 women aged 40 an…
Matched conditions: HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 26, 2026 04:14 UTC
-
Texts and calls boost breast cancer pill taking in major trial
Symptom relief OngoingThis study tests whether adding text message reminders and telephone counseling helps breast cancer patients take their daily hormone therapy pills more consistently. About 1,167 women with early-stage hormone receptor-positive breast cancer will be followed for up to two years. …
Matched conditions: HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC
-
Blood test may reveal hidden cancer after breast cancer surgery
Knowledge-focused TerminatedThis study looks at a blood test that finds tiny bits of tumor DNA in the blood of people with early-stage breast cancer. The goal is to see if this test can tell who still has cancer cells after treatment and might need more therapy. About 350 adults with stage I-III breast canc…
Matched conditions: HER2-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:10 UTC